Paroxysmal nocturnal hemoglobinuria‐phenotype cells predict a good response to eltrombopag in patients with refractory aplastic anemia

Abstract To identify factors affecting responsiveness to eltrombopag (EPAG), we retrospectively analyzed 38 aplastic anemia patients treated with EPAG who were refractory (n = 29) or showed an inadequate response (n = 9) to conventional therapies. The efficacy was evaluated at 16 weeks after startin...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Ken Ishiyama, Keijiro Sato, Tatsuya Imi, Kohei Hosokawa, Yukio Kondo, Naomi Sugimori, Hirohito Yamazaki, Shinji Nakao
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Wiley 2020-07-01
Rangatū:	eJHaem
Ngā marau:	aplastic anemia PNH thrombopoietin
Urunga tuihono:	https://doi.org/10.1002/jha2.51
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!